Exchange: NYSE·Updated 07:56 PM EST
RVTY logo

RVTY Revvity Inc.

$145.22
$6.37
(4.20%)
Today
Closed $145.22
$2.78
(1.91%)
After Hours
Reported EarningsNov 3
Mkt Cap$16.21B
Vol1.66M

About RVTY

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.
43

Bearish Sentiment

How do you feel about RVTY?

shoc24
$RVTY reported earnings this morning before the open and beat EPS estimates: $1.38 adjusted EPS vs $1.30 expected, according to Stock Meadow.
StocktwitsEarnings
$RVTY Q3 '26 Earnings Results & Recap Revvity forecasts full year 2026 pro forma total revenue of approximately $2.86B, pro forma organic revenue growth of approximately 5%, and pro forma adjusted EPS of $5.40-$5.45.

Advertisement|Remove ads.